Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 222,876,907 papers from all fields of science
Search
Sign In
Create Free Account
CGP 3466
Known as:
CGP-3466
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
HOE 077
omigapil
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2004
Review
2004
Glyceraldehyde-3-phosphate dehydrogenase as a target for small-molecule disease-modifying therapies in human neurodegenerative disorders.
M. D. Berry
Journal of Psychiatry & Neuroscience
2004
Corpus ID: 6320004
Recent articles have highlighted numerous additional functions of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) that are…
Expand
Review
2002
Review
2002
Aliphatic propargylamines as symptomatic and neuroprotective treatments for neurodegenerative diseases.
M. D. Berry
,
A. Boulton
Neurotoxicology and Teratology
2002
Corpus ID: 21362577
1999
1999
Dibenzoxepines as treatments for neurodegenerative diseases
K. Zimmermann
,
P. Waldmeier
,
W. Tatton
1999
Corpus ID: 33172368
Abstract
Highly Cited
1998
Highly Cited
1998
Glyceraldehyde-3-phosphate Dehydrogenase, the Putative Target of the Antiapoptotic Compounds CGP 3466 andR-(−)-Deprenyl*
E. Kragten
,
Isabelle Lalande
,
+6 authors
P. Fürst
Journal of Biological Chemistry
1998
Corpus ID: 32615098
R-(−)-Deprenyl (Selegiline) represents one of the drugs currently used for the treatment of Parkinson’s disease. This compound…
Expand
1998
1998
Synthesis of tools for target identification of the anti-apoptotic compound CGP 3466; Part I.
K. Zimmermann
,
S. Roggo
,
E. Kragten
,
P. Fürst
,
P. Waldmeier
Bioorganic & Medicinal Chemistry Letters
1998
Corpus ID: 28650398
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE